Serology-informed estimates of SARS-COV-2 infection fatality risk in Geneva, Switzerland
Javier Perez-Saez, Stephen A Lauer, Laurent Kaiser, Simon Regard, Elisabeth Delaporte, Idris Guessous, Silvia Stringhini, Andrew S Azman, for the Serocov-POP Study Group
doi: https://doi.org/10.1101/2020.06.10.20127423
Javier Perez-Saez
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA
2Institute of Global Health, Faculty of Medicine, University of Geneva, Switzerland
Stephen A Lauer
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA
Laurent Kaiser
3Geneva Center for Emerging Viral Diseases and Laboratory of Virology, Geneva University Hospitals, Switzerland
4Division of Laboratory Medicine, Geneva University Hospitals, Switzerland
5Faculty of Medicine, University of Geneva, Switzerland
Simon Regard
6Department of Acute Medicine, Division of Emergency, Geneva University Hospitals, Switzerland
7Cantonal Health Service, General Directorate for Health, Geneva, Switzerland
Elisabeth Delaporte
7Cantonal Health Service, General Directorate for Health, Geneva, Switzerland
Idris Guessous
5Faculty of Medicine, University of Geneva, Switzerland
8Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Switzerland
Silvia Stringhini
5Faculty of Medicine, University of Geneva, Switzerland
8Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Switzerland
Andrew S Azman
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA
2Institute of Global Health, Faculty of Medicine, University of Geneva, Switzerland
Posted June 12, 2020.
Serology-informed estimates of SARS-COV-2 infection fatality risk in Geneva, Switzerland
Javier Perez-Saez, Stephen A Lauer, Laurent Kaiser, Simon Regard, Elisabeth Delaporte, Idris Guessous, Silvia Stringhini, Andrew S Azman, for the Serocov-POP Study Group
medRxiv 2020.06.10.20127423; doi: https://doi.org/10.1101/2020.06.10.20127423
Serology-informed estimates of SARS-COV-2 infection fatality risk in Geneva, Switzerland
Javier Perez-Saez, Stephen A Lauer, Laurent Kaiser, Simon Regard, Elisabeth Delaporte, Idris Guessous, Silvia Stringhini, Andrew S Azman, for the Serocov-POP Study Group
medRxiv 2020.06.10.20127423; doi: https://doi.org/10.1101/2020.06.10.20127423
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (191)
- Cardiovascular Medicine (2840)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (802)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (221)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)